01-01-1970 12:00 AM | Source: Accord Fintech
Glenmark Life Sciences files DRHP for IPO with SEBI
Glenmark Life Sciences has filed a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for an initial public offer (IPO). Glenmark Life Sciences is a wholly-owned subsidiary of Glenmark Pharmaceuticals.
The offer comprises fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73,05,245 equity shares of Rs 2 each of Glenmark Life Sciences, by Glenmark Pharmaceuticals.
The board of directors of Glenmark Pharmaceuticals during its meeting on April 16 approved the offer for sale of up to 73,05,245 equity shares of Rs 2 apiece as part of the IPO. The IPO will be subject to market conditions, receipt of applicable approvals and other considerations.
Latest News
SAIL inks pact with Administrative Staff College of ...
NSE clocks 57 pc surge in net profit at Rs 3,137 cro...
Sell Johnson Controls-Hitachi Air Conditioning Ltd ...
Kartik Aaryan mobbed by fans at Mumbai?s Gaiety Gala...
Sarbananda Sonowal inaugurates key infra projects to...
B?town divas Kriti Sanon, Dhanashree Verma spotted a...
Kartik Aryan spotted in Mumbai
Rollover Analysis Report - November-2024 by Religare...
Neutral TVS Motor Company Ltd For Target Rs.2,610 By...
Buy SBI Life Insurance Ltd For Target Rs.2,100 By Mo...